The novel treatment of the medication represents a significant breakthrough in the care of the condition. Distinct from existing therapies, tirzepatide affects dual pathways – GLP-1 and the GIP hormone – leading to https://tirzepatidepeptide484320.ttblogs.com/21961162/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment